Aims and objectives
to compare the incidence of breast cancer between two group in the same population already checked by screening program: first group is madeof the symptom recalls and the second group is made of second level screening in order to evaluate the symptom as a positive predictive value.
Methods and materials
We reviewed a retrospective cohort of 3752 patients involved in second level screening program for breast cance,
in a single Italian center,
between January 2010 and September 2018.
We evaluated two different groups: the symptom recall (SR) and second level recall excluding symptom recall (LR).
We compared the incidence of breast cancer between the two groups.
We classified as acceptable a symptom recall which was maximum of 6 months earlier than the official call.
we obtained a final cohort of 176 Symptom Recall (SR) group with a total of 24 cases of cancer where the incidence was 12%.
We analyzed 3376 cases of second Level Recall (LR) group with a total of 216 cases of cancer where the incidence was 6,39%.
In 15 cases of cancer in SR group 15 (62%) have been evalueted with a not acceptable time between symptom and timing of screening program
Our results show how the symptom is a certain positive predictive value (PPV) even in a screened women population.
Our study suggests that a shorter follow-up than 2 years,
which is the nowdays italian timing,
it could be a better timing for screening program in order to avoid diagnosis of cancer as a palpable lesion and decrease the anxiety in woman with palpable breast mass.
Mammography : an update of the EUSOBI recommendations on information for women. Sardanelli F,
Forrai G; European Society of Breast Imaging (EUSOBI),
with language review by Europa Donna–The European Breast Cancer Coalition. The relevance of reported symptoms in a breast screening programme. Williams RS,
Gower-Thomas K. Compliance With Screening Mammography Guidelines After a False-Positive Mammogram ....